advertisement

WGA Rescources

Journal of Ocular Pharmacology and Therapeutics 8

Showing records 1 to 8 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

57349 Matricellular proteins in the trabecular meshwork: review and update
Chatterjee A; Villarreal G; Rhee DJ
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 447-463
57127 Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers
Iester M; Telani S; Frezzotti P; Motolese I; Figus M; Fogagnolo P; Perdicchi A;
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 476-481
57022 Investigation of ocular events associated with taprenepag isopropyl, a topical EP2 agonist in development for treatment of glaucoma
Yanochko GM; Affolter T; Eighmy JJ; Evans MG; Khoh-Reiter S; Lee D; Miller PE; Shiue MH; Trajkovic D; Jessen BA
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 429-439
57051 Effects of long-term topical prostaglandin therapy on central corneal thickness
Maruyama Y; Mori K; Ikeda Y; Ueno M; Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 440-444
57348 Effects of Polyquaternium- and Benzalkonium-Chloride-Preserved Travoprost on Ocular Surfaces: An Impression Cytology Study
Sezgin Akçay BI; Güney E; Bozkurt TK; Topal CS; Akkan JC; Unlü C
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 548-553
57453 Neuroprotective Effect of Curcumin Against Oxidative Damage in BV-2 Microglia and High Intraocular Pressure Animal Model
Yue YK; Mo B; Zhao J; Yu YJ; Liu L; Yue CL; Liu W
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 657-664
57052 Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients
Holló G; Hommer A; Antón López A; Ropo A
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 468-475
57381 Does the Use of Preoperative Antiglaucoma Medications Influence Trabeculectomy Success?
Oztürker ZK; Oztürker C; Bayraktar S; Altan C; Yilmaz OF
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 554-558

Issue 16-2

Change Issue


advertisement

Oculus